One study reported a possible role of alphaIIbbeta3/SERT associations as well as alphaIIbbeta3 activation in control of SERT activity in vivo that may have broad implications for hyperserotonemia, cardiovascular disorders, and autism [37]. The gene discussed is SLC6A4; the disease is autism.